Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02161172
Other study ID # 658214
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 2012
Est. completion date May 2014

Study information

Verified date August 2020
Source Shanghai 6th People's Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Patients with traumatic brain injury are likely to present with cognitive, psychological, emotional and behavioral problems during different periods, all of which affect patients' life quality seriously. The aim of this study was to assess cognitive and psychosocial outcome in patients with mild traumatic brain injury, and to determine the risk factors associated with cognitive and psychological outcome. Mini-mental state examination (MMSE), activities of daily living scale (ADL), the Hospital Anxiety Depression Scale (HADS) and mental health symptom checklist (SCL-90) were used to assess the cognitive performance and psychological outcomes in 360 patients with mild traumatic brain injury. Chi-square, Fisher's exact tests and Logistic regression analysis were used to analyze the risk factors.


Recruitment information / eligibility

Status Completed
Enrollment 360
Est. completion date May 2014
Est. primary completion date April 2014
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- 18 ~ 60 years old

- Education: primary school and above, who could understand the content of psychological test

- History of brain trauma

- No taking of antipsychotic or any other drugs affecting central nervous system before the test

- Glasgow coma score (GCS) was 13-15

Exclusion Criteria:

- History of craniocerebral injury, brain disease, mental disease

- With mental retardation

- with other serious body diseases

- History of drug and alcohol dependence

- With color-blind or color weakness

- Who had severe visual and auditory disorders after brain injury

- Who failed or failed in completing the test effectively

- With cognitive impairment caused by the damage of the unilateral frontal or bilateral lobes, or with language dysfunction caused by temporal lobe damage

Study Design


Locations

Country Name City State
China Shanghai Sixth People's Hospital Shanghai

Sponsors (1)

Lead Sponsor Collaborator
Shanghai 6th People's Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Other Hospital anxiety and depression Scale The scale includes 14 items and each has 0-3 points. The score of the former seven items > 7, indicating depression symptom; the later seven items > 7, indicating anxiety symptom. 6 months
Other Symptom Check-List 90 This scale has been widely used to patients with neurosis, adjustment disorder and other slight mental psychological disorder. According to the national norm results, if the total score > 160, or the number of positive items > 43, or one factor score >2, we consider the positive screening. 6 months
Primary Mini-Mental State Examination MMSE includes seven factors, namely: the time orientation factor (5 points), place orientation (5 points), immediate memory (3 points), short-term memory (3 points), calculation capabilities (5 points), verbal expression, naming and repetition (4 points), speech reading and understanding (4 points), graphic depiction (1 points). The scales for the description of cognitive function impairment were grouped into three levels of education: illiteracy (17 points), primary school (20 points) and middle school (24 points). The one with score below average was considered with cognitive function impairment. 6 months
Secondary Activity of daily living scale The scale is divided into two parts: physical self-care ability, instrumental activities of daily living. 1 point for each option means normal; If 2~4 points for one option, he or she probably had ability decline; If two or more parts =3 points or total score= 22 points (14 questions), he or she exhibited living ability decline clearly. 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT04372797 - Standardized Instruments to Provide Diagnostic and Prognostic Information in Mild Traumatic Brain Injury (mTBI) N/A
Completed NCT01903525 - DHA For The Treatment of Pediatric Concussion Related to Sports Injury Phase 1
Completed NCT01847040 - Deployment Related Mild Traumatic Brain Injury (mTBI)
Completed NCT03678077 - Trends in Cohabitation Status, Academic Achievement and Socio-economic Indicators After Mild Traumatic Brain Injury
Recruiting NCT05682677 - Combined Neuromodulation and Cognitive Training for Post-mTBI Depression N/A
Terminated NCT03345550 - OPTIMA-TBI Pilot Study Phase 2
Completed NCT05095012 - RECOVER Clinical Pathway for Pediatric Concussion N/A
Recruiting NCT05886400 - The Effects of Environmental Distractions on SCAT6 Outcomes N/A
Recruiting NCT05262361 - Persistent Post-Concussion Symptoms With Convergence Insufficiency N/A
Active, not recruiting NCT03892291 - Objective Dual-task Turning Measures for Return-to-duty Assessments
Completed NCT03688984 - Treatment of Insomnia for Adolescents With Mild Traumatic Brain Injury N/A
Completed NCT02057081 - Multifamily Group to Reduce Marital Conflict and Disability in Veterans With mTBI N/A
Recruiting NCT06233851 - t-BIOMAP : Prospective Paediatric Cohort Study of Blood Biomarkers in mTBI
Completed NCT02844946 - One-Day Life Skills Workshop for Veterans With TBI, Pain and Psychopathology N/A
Completed NCT04641767 - BIOmarkers of TRAumatic Brain Injury Spain (BIOTRABIS)
Recruiting NCT06112093 - Repetitive Transcranial Magnetic Stimulation for Post-concussion Headaches N/A
Recruiting NCT03819608 - Neuromodulation and Neurorehabilitation for mTBI Plus PTSD N/A
Withdrawn NCT00580918 - Functional MRI Study of Attention in Normal Controls and Traumatic Brain Injured Patients
Completed NCT03319966 - Eyetracking and Neurovision Rehabilitation of Oculomotor Dysfunction in Mild Traumatic Brain Injury
Recruiting NCT03846830 - Incremental Velocity Error as a New Treatment in Vestibular Rehabilitation N/A